14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for FATE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.65 14.61 %
R2 4.48 10.38 %
R1 4.38 7.76 %
Current price: 4.06
Support S1 4.03 -0.704 %
S2 3.93 -3.32 %
S3 3.75 -7.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.79 17.98 %
R2 4.54 11.82 %
R1 4.09 0.739 %
Current price 4.06
Support S1 4.04 -0.493%
S2 3.95 -2.71%
S3 3.87 -4.68%

FATE Predictions History

1 year ago
PredictionBot.Warren predicted that FATE for 2023-04-28 is going $5.94 (-2.19%)

1 year ago
patostfk.353093 predicted that FATE for 2023-04-28 is going $2.00 (-65.75%)

Rank:

1 year ago
patostfk.353093 predicted that FATE for 2023-04-27 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that FATE for 2023-04-19 is going $6.07 (-4.63%)

1 year ago
PredictionBot.Warren predicted that FATE for 2023-04-19 is going $6.13 (-3.66%)

1 year ago
TomPritchett predicted that FATE for 2023-01-05 is going

Rank:

1 year ago
cory.wright.332745 predicted that FATE for 2023-01-03 is going

Rank:

4 years ago
GoldenNugget predicted that FATE for 2019-05-07 is going $17.26 (-3.61%)

5 years ago
NameNotImportant predicted that FATE for 2019-05-06 is going $17.49 (1.98%)

5 years ago
NameNotImportant predicted that FATE for 2019-04-29 is going $17.03 (-1.79%)

Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT